SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Tung N) "

Sökning: WFRF:(Tung N)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Tidskriftsartikel (refereegranskat)
  •  
2.
  • Forskningsöversikt (refereegranskat)
  •  
3.
  • Forskningsöversikt (refereegranskat)
  •  
4.
  • Tidskriftsartikel (refereegranskat)
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Aartsen, M. G., et al. (författare)
  • Multiwavelength follow-up of a rare IceCube neutrino multiplet
  • 2017
  • Ingår i: Astronomy and Astrophysics. - : EDP SCIENCES S A. - 0004-6361 .- 1432-0746. ; 607
  • Tidskriftsartikel (refereegranskat)abstract
    • On February 17, 2016, the IceCube real-time neutrino search identified, for the first time, three muon neutrino candidates arriving within 100 s of one another, consistent with coming from the same point in the sky. Such a triplet is expected once every 13.7 years as a random coincidence of background events. However, considering the lifetime of the follow-up program the probability of detecting at least one triplet from atmospheric background is 32%. Follow-up observatories were notified in order to search for an electromagnetic counterpart. Observations were obtained by Swift's X-ray telescope, by ASAS-SN, LCO and MASTER at optical wavelengths, and by VERITAS in the very-high-energy gamma-ray regime. Moreover, the Swift BAT serendipitously observed the location 100 s after the first neutrino was detected, and data from the Fermi LAT and HAWC observatory were analyzed. We present details of the neutrino triplet and the follow-up observations. No likely electromagnetic counterpart was detected, and we discuss the implications of these constraints on candidate neutrino sources such as gamma-ray bursts, core-collapse supernovae and active galactic nucleus flares. This study illustrates the potential of and challenges for future follow-up campaigns.
  •  
10.
  • Hollestelle, Antoinette, et al. (författare)
  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
  • Ingår i: Gynecologic Oncology. - : Academic Press. - 0090-8258 .- 1095-6859. ; 141:2, s. 386-401
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3′ UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particular subgroups, were relatively small. Therefore, we comprehensively evaluated ovarian and breast cancer risks as well as clinical outcome associated with rs61764370. Methods Centralized genotyping and analysis were performed for 140,012 women enrolled in the Ovarian Cancer Association Consortium (15,357 ovarian cancer patients; 30,816 controls), the Breast Cancer Association Consortium (33,530 breast cancer patients; 37,640 controls), and the Consortium of Modifiers of BRCA1 and BRCA2 (14,765 BRCA1 and 7904 BRCA2 mutation carriers). Results We found no association with risk of ovarian cancer (OR = 0.99, 95% CI 0.94-1.04, p = 0.74) or breast cancer (OR = 0.98, 95% CI 0.94-1.01, p = 0.19) and results were consistent among mutation carriers (BRCA1, ovarian cancer HR = 1.09, 95% CI 0.97-1.23, p = 0.14, breast cancer HR = 1.04, 95% CI 0.97-1.12, p = 0.27; BRCA2, ovarian cancer HR = 0.89, 95% CI 0.71-1.13, p = 0.34, breast cancer HR = 1.06, 95% CI 0.94-1.19, p = 0.35). Null results were also obtained for associations with overall survival following ovarian cancer (HR = 0.94, 95% CI 0.83-1.07, p = 0.38), breast cancer (HR = 0.96, 95% CI 0.87-1.06, p = 0.38), and all other previously-reported associations. Conclusions rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers. Therefore, genotyping this variant has no clinical utility related to the prediction or management of these cancers.
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (99)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (100)
övrigt vetenskapligt (1)
Författare/redaktör
Friedman, E. (57)
Lubinski, J (37)
Chenevix-Trench, G (34)
Easton, DF (34)
Nevanlinna, H (33)
Offit, K (33)
visa fler...
Benitez, J. (32)
Neuhausen, SL (32)
Hamann, U (32)
Andrulis, IL (31)
Jakubowska, A (31)
Antoniou, AC (31)
Couch, FJ (30)
Singer, CF (30)
Thomassen, M (30)
Isaacs, C (30)
Wendt, C. (29)
Radice, P (29)
Meindl, A (29)
Caldes, T (29)
Toland, AE (28)
Andrulis, Irene L. (28)
Osorio, A (28)
Kim, J. (27)
Simard, J (27)
Antoniou, Antonis C. (27)
Couch, Fergus J. (27)
De Clercq, C. (26)
Hultqvist, K. (26)
Maggi, G. (26)
Merino, G. (26)
Peterlongo, P (26)
Neuhausen, Susan L (26)
Easton, Douglas F. (26)
Schmutzler, RK (26)
Gronwald, J (26)
Nevanlinna, Heli (25)
Botner, Olga (25)
Fahey, S. (25)
Huber, M. (25)
Robertson, S. (25)
Sarkar, S. (25)
Walck, C. (25)
Hultqvist, Klas (25)
Goldgar, DE (25)
Olah, E (25)
Domchek, Susan M. (25)
Singer, Christian F. (25)
Greene, Mark H. (25)
Godwin, Andrew K. (25)
visa färre...
Lärosäte
Karolinska Institutet (47)
Uppsala universitet (37)
Lunds universitet (29)
Stockholms universitet (25)
Göteborgs universitet (11)
Umeå universitet (6)
visa fler...
Linköpings universitet (5)
Kungliga Tekniska Högskolan (3)
Högskolan i Skövde (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (101)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (48)
Naturvetenskap (31)
Samhällsvetenskap (2)
Teknik (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy